Diabetes

12345678910
Across
  1. 4. Brand name of the first oral GLP-1 agonist
  2. 7. DAPA-HF showed CV risk reduction in patients with HF regardless of whether the patient had diabetes
  3. 8. Medication to avoid with a personal or family history of bladder cancer
  4. 9. SGLT2 inhibitor that showed increased risk of amputations in the CANVAS-RENAL Trial
  5. 10. Average weight loss in pounds seen with Ozempic
Down
  1. 1. Most common adverse effect of a GLP-1 agonist
  2. 2. The only DPP-IV inhibitor you do not have to renally dose adjust
  3. 3. First line treatment for Type 2 diabetes
  4. 5. Longest acting insulin
  5. 6. Generic name of empagliflozin